T

Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075

Watchlist Manager
Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
Watchlist
Price: 67.9 CNY -0.75% Market Closed
Market Cap: ¥5.4B

Profitability Summary

Tibet Duo Rui Pharmaceutical Co Ltd's profitability score is 22/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score
22/100
Profitability
Score

Margins

Earnings Waterfall
Tibet Duo Rui Pharmaceutical Co Ltd

Margins Comparison
Tibet Duo Rui Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
5.4B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
533.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.8B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.5B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
96.9B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Tibet Duo Rui Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
5.4B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
533.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.5B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
96.9B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Tibet Duo Rui Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate